Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gang Zou

Showing results (341-350 of 358) with videos related to

Pageof 36
Sort By:
Journal of Virology|December 9, 2025
Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTACQi Yang, Bao Xue, Xianjie Qiu, et al.
The Lancet. Child & Adolescent Health|April 17, 2025
Efficacy and safety of ziresovir in hospitalised infants aged 6 months or younger with respiratory syncytial virus infection in China: findings from a phase 3 randomised trial with 24-month follow-upHan Zhang, Wei Zhao, Xiaoyan Zhang, et al.
Genes|April 3, 2021
Whole Genome Sequencing in the Evaluation of Fetal Structural Anomalies: A Parallel Test with Chromosomal Microarray Plus Whole Exome SequencingJia Zhou, Ziying Yang, Jun Sun, et al.
Human Molecular Genetics|March 7, 2024
Comparative analysis of in-silico tools in identifying pathogenic variants in dominant inherited retinal diseasesDaniel C Brock, Meng Wang, Hafiz Muhammad Jafar Hussain, et al.
Protein & Cell|August 6, 2020
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2Rui Xiong, Leike Zhang, Shiliang Li, et al.
Virologica Sinica|September 10, 2020
Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In VitroLeike Zhang, Jia Liu, Ruiyuan Cao, et al.
Influenza and Other Respiratory Viruses|July 28, 2023
Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trialLi-Min Huang, Andreas Schibler, Yi-Chuan Huang, et al.
The Journal of Biological Chemistry|December 15, 2010
Small molecule inhibitors that selectively block dengue virus methyltransferaseSiew Pheng Lim, Louis Sebastian Sonntag, Christian Noble, et al.
National Science Review|November 23, 2022
An all-round AI-Chemist with a scientific mindQing Zhu, Fei Zhang, Yan Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2018
Spectrum of Enterovirus Serotypes Causing Uncomplicated Hand, Foot, and Mouth Disease and Enteroviral Diagnostic Yield of Different Clinical SamplesLidong Gao, Gang Zou, Qiaohong Liao, et al.
Pageof 36

Showing results (341-350 of 358) with videos related to

Sort By:
Pageof 36
Journal of Virology|December 9, 2025
Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTACQi Yang, Bao Xue, Xianjie Qiu, et al.
The Lancet. Child & Adolescent Health|April 17, 2025
Efficacy and safety of ziresovir in hospitalised infants aged 6 months or younger with respiratory syncytial virus infection in China: findings from a phase 3 randomised trial with 24-month follow-upHan Zhang, Wei Zhao, Xiaoyan Zhang, et al.
Genes|April 3, 2021
Whole Genome Sequencing in the Evaluation of Fetal Structural Anomalies: A Parallel Test with Chromosomal Microarray Plus Whole Exome SequencingJia Zhou, Ziying Yang, Jun Sun, et al.
Human Molecular Genetics|March 7, 2024
Comparative analysis of in-silico tools in identifying pathogenic variants in dominant inherited retinal diseasesDaniel C Brock, Meng Wang, Hafiz Muhammad Jafar Hussain, et al.
Protein & Cell|August 6, 2020
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2Rui Xiong, Leike Zhang, Shiliang Li, et al.
Virologica Sinica|September 10, 2020
Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In VitroLeike Zhang, Jia Liu, Ruiyuan Cao, et al.
Influenza and Other Respiratory Viruses|July 28, 2023
Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trialLi-Min Huang, Andreas Schibler, Yi-Chuan Huang, et al.
The Journal of Biological Chemistry|December 15, 2010
Small molecule inhibitors that selectively block dengue virus methyltransferaseSiew Pheng Lim, Louis Sebastian Sonntag, Christian Noble, et al.
National Science Review|November 23, 2022
An all-round AI-Chemist with a scientific mindQing Zhu, Fei Zhang, Yan Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2018
Spectrum of Enterovirus Serotypes Causing Uncomplicated Hand, Foot, and Mouth Disease and Enteroviral Diagnostic Yield of Different Clinical SamplesLidong Gao, Gang Zou, Qiaohong Liao, et al.
Pageof 36